CanniMed Therapeutics 

GB Group plc is an international enterprise specializing in data intelligence and identity verification services, with a significant presence in the United Kingdom, the United States, and Australia. The company organizes its activities into three primary divisions: Location, Identity, and Fraud. Its advanced solutions empower businesses to precisely identify and authenticate their customers' identities throughout their operational processes. Among its offerings are location intelligence services, which encompass accurate address capture and validation, digital identity confirmation, geographical coding, and data upkeep. Furthermore, GB Group provides essential identity, document, and age verification solutions. To combat fraud and ensure compliance, the company offers sophisticated tools for fraud risk assessment and decision-making, real-time transaction oversight, Know Your Customer (KYC) risk management, and anti-money laundering (AML) support. Serving a broad spectrum of industries, including e-commerce and retail, financial technology, traditional financial services, insurance, telecommunications, gaming, banking, vehicle hire, and pensions, as well as public sector bodies and entertainment establishments, GB Group was established in 1989 and is based in Chester, United Kingdom.